<code id='F6951F39A0'></code><style id='F6951F39A0'></style>
    • <acronym id='F6951F39A0'></acronym>
      <center id='F6951F39A0'><center id='F6951F39A0'><tfoot id='F6951F39A0'></tfoot></center><abbr id='F6951F39A0'><dir id='F6951F39A0'><tfoot id='F6951F39A0'></tfoot><noframes id='F6951F39A0'>

    • <optgroup id='F6951F39A0'><strike id='F6951F39A0'><sup id='F6951F39A0'></sup></strike><code id='F6951F39A0'></code></optgroup>
        1. <b id='F6951F39A0'><label id='F6951F39A0'><select id='F6951F39A0'><dt id='F6951F39A0'><span id='F6951F39A0'></span></dt></select></label></b><u id='F6951F39A0'></u>
          <i id='F6951F39A0'><strike id='F6951F39A0'><tt id='F6951F39A0'><pre id='F6951F39A0'></pre></tt></strike></i>

          fashion

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Why failed clinical trials don’t always spell doom for a new drug
          Why failed clinical trials don’t always spell doom for a new drug

          AdobeThisarticlewasadaptedfromSTAT’slatestreport,“Failedtrial,successfuldrug:howanegativereadoutcans

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Biogen walks away from Aduhelm, years after polarizing approval

          JessicaRinaldi/TheBostonGlobeBiogenisgivingupitsownershipofAduhelm,theAlzheimer’sdiseasetreatmentwho